|

Ipilimumab (1mg/kg) Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Sun Yat-sen University1
  • Gazi University1

Indications

  • Cancer2
  • Metastatic Nonsmall Cell Lung Cancer1
  • Nonsmall Cell Lung Cancer, Stage IV1
  • Esophageal Squamous Cell Carcinoma (ESCC)1
  • Lung Cancer1

Other2 trials

Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer
Phase 2
Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.